Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2005 2
2006 1
2007 1
2008 3
2009 4
2010 1
2011 3
2012 2
2013 2
2014 3
2015 2
2016 2
2017 3
2018 1
2019 1
2020 2
2021 6
2022 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Novel therapeutic approaches for pulmonary fibrosis.
Datta A, Scotton CJ, Chambers RC. Datta A, et al. Among authors: scotton cj. Br J Pharmacol. 2011 May;163(1):141-72. doi: 10.1111/j.1476-5381.2011.01247.x. Br J Pharmacol. 2011. PMID: 21265830 Free PMC article. Review.
Bleomycin revisited: towards a more representative model of IPF?
Scotton CJ, Chambers RC. Scotton CJ, et al. Am J Physiol Lung Cell Mol Physiol. 2010 Oct;299(4):L439-41. doi: 10.1152/ajplung.00258.2010. Epub 2010 Jul 30. Am J Physiol Lung Cell Mol Physiol. 2010. PMID: 20675435 Free article. No abstract available.
Investigating the role of platelets and platelet-derived transforming growth factor-β in idiopathic pulmonary fibrosis.
Chong DLW, Mikolasch TA, Sahota J, Rebeyrol C, Garthwaite HS, Booth HL, Heightman M, Denneny EK, José RJ, Khawaja AA, Duckworth A, Labelle M, Scotton CJ, Porter JC. Chong DLW, et al. Among authors: scotton cj. Am J Physiol Lung Cell Mol Physiol. 2023 Oct 1;325(4):L487-L499. doi: 10.1152/ajplung.00227.2022. Epub 2023 Aug 29. Am J Physiol Lung Cell Mol Physiol. 2023. PMID: 37643008 Free PMC article.
Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK.
Dixon G, Hague S, Mulholland S, Adamali H, Khin AMN, Thould H, Connon R, Minnis P, Murtagh E, Khan F, Toor S, Lawrence A, Naqvi M, West A, Coker RK, Ward K, Yazbeck L, Hart S, Garfoot T, Newman K, Rivera-Ortega P, Stranks L, Beirne P, Bradley J, Rowan C, Agnew S, Ahmad M, Spencer LG, Aigbirior J, Fahim A, Wilson AM, Butcher E, Chong SG, Saini G, Zulfikar S, Chua F, George PM, Kokosi M, Kouranos V, Molyneaux P, Renzoni E, Vitri B, Wells AU, Nicol LM, Bianchi S, Kular R, Liu H, John A, Barth S, Wickremasinghe M, Forrest IA, Grimes I, Simpson AJ, Fletcher SV, Jones MG, Kinsella E, Naftel J, Wood N, Chalmers J, Crawshaw A, Crowley LE, Dosanjh D, Huntley CC, Walters GI, Gatheral T, Plum C, Bikmalla S, Muthusami R, Stone H, Rodrigues JCL, Tsaneva-Atanasova K, Scotton CJ, Gibbons MA, Barratt SL. Dixon G, et al. Among authors: scotton cj. ERJ Open Res. 2024 Jan 15;10(1):00529-2023. doi: 10.1183/23120541.00529-2023. eCollection 2024 Jan. ERJ Open Res. 2024. PMID: 38226064 Free PMC article.
45 results